Pembrolizumab
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12603 publications
Immunotherapy Response in Microsatellite Instability-High Gastroesophageal Adenocarcinoma.
Journal: JAMA surgery
Published: April 15, 2026
Update on pleural mesothelioma.
Journal: Current opinion in pulmonary medicine
Published: April 15, 2026
Efficacy of Perioperative Pembrolizumab in Mismatch Repair Deficient/Microsatellite Unstable Localized Colorectal Cancers: Results of the Phase II Trial IMHOTEP.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: April 14, 2026
Cost of care and budget impact of novel first-line treatments in patients with locally advanced or metastatic urothelial carcinoma from the Colombian healthcare system perspective.
Journal: Expert review of pharmacoeconomics & outcomes research
Published: April 14, 2026
mRNA vaccines in oncology: personalized cancer immunization and neoantigen targeting.
Journal: Molecular & cellular oncology
Published: April 13, 2026
Comparative pharmacovigilance signals for PD-1, PD-L1, CTLA-4, and LAG-3 immune checkpoint inhibitor-associated hemophagocytic lymphohistiocytosis in the FAERS database.
Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Published: April 13, 2026
Pembrolizumab plus chemotherapy for advanced HER2-negative gastric or gastroesophageal junction cancer: KEYNOTE-859 Q-TWiST analysis.
Journal: Immunotherapy
Published: April 11, 2026
Genome-Wide Variations of End Motif in Cell-Free DNA Fragments Distinguish Immunotherapy Responders from Non-Responders in Head and Neck Cancer: A Multi-Institute Prospective Study.
Journal: medRxiv : the preprint server for health sciences
Published: April 10, 2026
The game changer in the cervical cancer therapeutic landscape: immunotherapy.
Journal: Immunotherapy
Published: April 10, 2026
Extrapolation of Time-to-Event Survival Outcomes of Histology-Independent Therapies Using a Bayesian Hierarchical Model.
Journal: Medical decision making : an international journal of the Society for Medical Decision Making
Published: April 10, 2026
Last Updated: 04/28/2026